Arrivent Biopharma, Inc.
SEC CIK 1868279 · AVBP · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Peterson Kristine | Director | filed 2024 - 2026 |
| Hohneker John | Director | filed 2024 - 2026 |
| Nolet Chris | Director | filed 2024 - 2026 |
| Parsey Merdad | Director | filed 2025 - 2026 |
| Yao Zhengbin | Director · President and CEO | filed 2024 - 2026 |
| Lutzker Stuart | Director · President of R&D | filed 2024 - 2026 |
| Orbimed Advisors LLC | Director | filed 2024 - 2024 |
| Healy James | Director | filed 2024 - 2024 |
| Gordon Carl L | Director | filed 2024 - 2024 |
| Orbimed Capital GP Viii LLC | Director | filed 2024 - 2024 |
| Orbimed Advisors IV Ltd | Director | filed 2024 - 2024 |
| Orbimed Asia GP IV, L.P. | Director | filed 2024 - 2024 |
| Jallal Bahija | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kung Winston | Chief Financial Officer | filed 2024 - 2026 |
| Kastenmayer James Paul | General Counsel | filed 2024 - 2026 |
| Lachapelle Robin | Chief Operating Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.